TheraRadar
Data updated: May 26, 2026

BENAZEPRIL HYDROCHLORIDE

Cardiovascular Approved 2004-02-11

BENAZEPRIL HYDROCHLORIDE is indicated for the treatment of Hypertension.

Source: FDA Label • CHARTWELL RX
5
Indications
--
Phase 3 Trials
22
Years on Market

BENAZEPRIL HYDROCHLORIDE Approval History

2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
398 FDA actions from 2004 to 2026
Jan 2026 SUPPL
Mfg · Manufacturing (CMC)
Mar 2025 SUPPL
Label · Labeling
Jul 2020 SUPPL
Label · Labeling

What BENAZEPRIL HYDROCHLORIDE Treats

1 indications

BENAZEPRIL HYDROCHLORIDE is approved for 1 conditions since its original approval in 2004. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypertension
Source: FDA Label

BENAZEPRIL HYDROCHLORIDE Boxed Warning

FETAL TOXICITY When pregnancy is detected, discontinue benazepril hydrochloride tablets as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions ( 5.1 )]. WARNING-FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue benazepril hydrochloride tablets as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin s...

BENAZEPRIL HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to BENAZEPRIL HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACEBUTOLOL HYDROCHLORIDE
ACEBUTOLOL HYDROCHLORIDE
1 shared
PHARMOBEDIENT
Shared indications:
ALDACTONE
SPIRONOLACTONE
1 shared
Pfizer
Shared indications:
ALISKIREN HEMIFUMARATE
ALISKIREN HEMIFUMARATE
1 shared
PH HEALTH
Shared indications:
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT01234922 results posted IRB00014933 NCI-2010-02043, IRB00014933 Ph 2 terminated Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
NCT01095939 RPPEC 09-136 Ph 3 completed Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BENAZEPRIL HYDROCHLORIDE FDA Label Details

Indications & Usage

BENAZEPRIL HYDROCHLORIDE is indicated for the treatment of Hypertension.

⚠️ BOXED WARNING

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue benazepril hydrochloride tablets as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions ( 5.1 )]. WARNING-FETAL TOXICITY See ...

Looking for the branded version?

LOTENSIN

Full clinical data, patents, trials, and competitive landscape for benazepril hydrochloride.

See LOTENSIN

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.